Results tomorrow will be very interesting
New product cycle has favoured phillips recently and with Resmed now in the early stages of one hopefully we will see some good signs of it in the earnings tomorrow.
Also, comments at the last presentation hinted at some progress with the transition from regulation changes in America. That has been a headwind that hopefully is not a permanent...
- Forums
- ASX - By Stock
- RMD
- rmd innovation excellence wins two awards
rmd innovation excellence wins two awards, page-2
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$36.04 |
Change
-0.620(1.69%) |
Mkt cap ! $22.01B |
Open | High | Low | Value | Volume |
$35.95 | $36.08 | $35.49 | $58.29M | 1.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 27 | $35.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$36.05 | 12289 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27 | 35.960 |
1 | 15 | 35.950 |
1 | 576 | 35.940 |
1 | 750 | 35.900 |
1 | 19 | 35.810 |
Price($) | Vol. | No. |
---|---|---|
36.050 | 200 | 1 |
36.060 | 700 | 1 |
36.100 | 549 | 2 |
36.500 | 200 | 1 |
36.570 | 280 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online